Homology Medicines racks up $83.5 mln Series B
Bedford, Massachusetts-based Homology Medicines Inc, a genetic medicines company, has raised $83.5 million in Series B financing. Deerfield Management led the round with participation from Fidelity Management and Research Company, HBM Healthcare Investments, Maverick Ventures, Novartis, Rock Springs Capital, Vida Ventures, Vivo Capital, Alexandria Venture Investments, 5AM Ventures, ARCH Venture Partners and Temasek.
1 August 2017•1 min read
